North Bristol NHS Trust
Bristol, United Kingdom
Dr John Pauling is a consultant rheumatologist at North Bristol NHS Trust and Honorary Senior Lecturer at the University of Bristol Medical School. John was awarded the Arthritis Research Campaign Medal before qualifying from Nottingham University Medical School in 2002. In 2009 he was awarded the Dando fellowship, jointly funded by the Raynaud’s & Scleroderma Association and Royal College of Physicians. His PhD research helped John to develop an interest in outcome measures in Systemic sclerosis research, particularly in relation to peripheral microvascular dysfunction in Raynaud's phenomenon and systemic sclerosis. John has interests in patient-reported outcome instruments in systemic sclerosis and non-invasive methods of measuring tissue perfusion such as nailfold capillaroscopy, infra-red thermography and laser-derived imaging modalities. John is a member of the EULAR Microcirculation study group and has contributed to recent initiatives of the UK Scleroderma Study Group. John sits on the executive committee of the Scleroderma Clinical Trials Consortium (SCTC) and leads the SCTC Vascular Working Group that is currently undertaking work to develop novel outcome measures for Raynaud’s phenomenon and digital ulcer disease in systemic sclerosis.
Emerging Strategies for Evaluating and Treating Raynaud's Phenomenon and Digital Ulcer
Tuesday, October 28, 2025
11:00 AM – 11:30 AM Central Time
Disclosure(s): AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Johnson & Johnson: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)